Seaport Therapeutics, Inc.
NASDAQSPTX short squeeze risk fades as utilization maxes at 100%, availability falls to 0.19%—shares nearly impossible to borrow.
Seaport Therapeutics heads into its September 4 earnings event with the lending market completely exhausted and a fresh analyst initiation landing this week — a rare combination of maximum short pressure and growing…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SPTX — free to start on ORTEX.
Sign up for free →Open SPTX on ORTEXSnapshot as of 20 Sept 2026
Pulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live SPTX data →